About
Mark Leschly has served as a member of our board since 2002. Since July 1999, Mark Leschly has been a Managing Partner with Rho Capital Partners, an investment and venture capital management company.Previously,Mark Leschly was an Associate and then a General Partner of HealthCare Ventures, a venture capital management company, from 1994 through 1999. In addition to serving as a director of Verenium Corporation, NitroMed, Inc., and Tercica, Inc. (a wholly-owned subsidiary of Ipsen). Mark Leschly is on the board of a number of private companies. Mark Leschly received an A.B. from Harvard University and an M.B.A. from the Stanford Graduate School of Business.
Position in the VCSift Database
- • 2 investors at Rho Capital Partners are tracked.
- • 1,303 investors hold the Managing Partner role in VCSift. Mark Leschly is one of them.
- • 10,621 investors are based in New York, New York, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- New York, US
Contact Information
Find more investors like Mark
Search Investors